Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Report

Global and Region Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：207
  • REPORT CODE：GMM986540
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Dipeptide Peptidase 4 (DPP-4) Inhibitors are a class of oral diabetes drugs that work by blocking the action of DPP-4, an enzyme which destroys a group of gastrointestinal hormones called incretins. Incretins help stimulate the production of insulin when it is needed (e.g. after eating) and reduce the production of glucagon by the liver when it is not needed (e.g. during digestion). They also slow down digestion and decrease appetite. So by protecting incretins from damage, DPP-4 inhibitors help regulate blood glucose levels.

    Januvia (Sitagliptin), Galvus (Vildagliptin), Onglyza (Saxagliptin), Tradjenta (Linagliptin) are the major DPP-4 drugs in the market.

    The report details the trend, potential and market size of Dipeptide Peptidase 4 (DPP-4) Inhibitors market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Dipeptide Peptidase 4 (DPP-4) Inhibitorsmarket, defines the market attractiveness level of Dipeptide Peptidase 4 (DPP-4) Inhibitors market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Dipeptide Peptidase 4 (DPP-4) Inhibitors industry, describes the types of Dipeptide Peptidase 4 (DPP-4) Inhibitors market, the applications of major players and the market size, and deeply analyzes the current situation of the global Dipeptide Peptidase 4 (DPP-4) Inhibitors market and the development prospects and opportunities of Dipeptide Peptidase 4 (DPP-4) Inhibitors industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Dipeptide Peptidase 4 (DPP-4) Inhibitors market in Chapter 13.

    By Player:

    • AstraZenica

    • BMS

    • Merck

    • Eli Lilly

    • Boehringer Ingelheim

    • Takeda Pharmaceutical Company

    By Type:

    • Sitagliptin

    • Saxagliptin

    • Linagliptin

    • Alogliptin

    • Vildagliptin

    By End-User:

    • Hospitals

    • Clinics

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Dipeptide Peptidase 4 (DPP-4) Inhibitors Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Analysis and Outlook to 2022

    • 7.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption (2017-2022)

    • 7.2 United States Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption (2017-2022)

    • 7.3 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption (2017-2022)

    • 7.4 China Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption (2017-2022)

    • 7.5 Japan Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption (2017-2022)

    • 7.6 India Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption (2017-2022)

    • 7.7 South Korea Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption (2017-2022)

    8 Region and Country-wise Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Analysis and Outlook to 2028

    • 8.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption Forecast (2022-2028)

    • 8.2 United States Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption Forecast (2022-2028)

    • 8.3 Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption Forecast (2022-2028)

    • 8.4 China Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption Forecast (2022-2028)

    • 8.5 Japan Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption Forecast (2022-2028)

    • 8.6 India Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption Forecast (2022-2028)

    • 8.7 South Korea Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption Forecast (2022-2028)

    9 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Outlook by Types and Applications to 2022

    • 9.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Sitagliptin Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Saxagliptin Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Linagliptin Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Alogliptin Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Vildagliptin Consumption and Growth Rate (2017-2022)

    • 9.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

    10 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Outlook by Types and Applications to 2028

    • 10.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Sitagliptin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Saxagliptin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Linagliptin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Alogliptin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Vildagliptin Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    11 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Competitive Analysis

    • 14.1 AstraZenica

      • 14.1.1 AstraZenica Company Details

      • 14.1.2 AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Product and Service

    • 14.2 BMS

      • 14.2.1 BMS Company Details

      • 14.2.2 BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Product and Service

    • 14.3 Merck

      • 14.3.1 Merck Company Details

      • 14.3.2 Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Product and Service

    • 14.4 Eli Lilly

      • 14.4.1 Eli Lilly Company Details

      • 14.4.2 Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Product and Service

    • 14.5 Boehringer Ingelheim

      • 14.5.1 Boehringer Ingelheim Company Details

      • 14.5.2 Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Product and Service

    • 14.6 Takeda Pharmaceutical Company

      • 14.6.1 Takeda Pharmaceutical Company Company Details

      • 14.6.2 Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Dipeptide Peptidase 4 (DPP-4) Inhibitors

    • Figure Dipeptide Peptidase 4 (DPP-4) Inhibitors Picture

    • Table Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption by Country (2017-2022)

    • Figure United States Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption and Growth Rate (2017-2022)

    • Table Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure China Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Japan Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure India Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure South Korea Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption Forecast by Country (2022-2028)

    • Figure United States Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Dipeptide Peptidase 4 (DPP-4) Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Sitagliptin Consumption and Growth Rate (2017-2022)

    • Figure Global Saxagliptin Consumption and Growth Rate (2017-2022)

    • Figure Global Linagliptin Consumption and Growth Rate (2017-2022)

    • Figure Global Alogliptin Consumption and Growth Rate (2017-2022)

    • Figure Global Vildagliptin Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Sitagliptin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Saxagliptin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Linagliptin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Alogliptin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vildagliptin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Dipeptide Peptidase 4 (DPP-4) Inhibitors Export by Region (Top 5 Countries) (2017-2028)

    • Table AstraZenica (Foundation Year, Company Profile and etc.)

    • Table AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZenica Dipeptide Peptidase 4 (DPP-4) Inhibitors Product and Service

    • Table BMS (Foundation Year, Company Profile and etc.)

    • Table BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

    • Table BMS Dipeptide Peptidase 4 (DPP-4) Inhibitors Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Dipeptide Peptidase 4 (DPP-4) Inhibitors Product and Service

    • Table Eli Lilly (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly Dipeptide Peptidase 4 (DPP-4) Inhibitors Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Dipeptide Peptidase 4 (DPP-4) Inhibitors Product and Service

    • Table Takeda Pharmaceutical Company (Foundation Year, Company Profile and etc.)

    • Table Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Pharmaceutical Company Dipeptide Peptidase 4 (DPP-4) Inhibitors Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US